Sales & Earnings In Brief: Merck evaluates consumer business, Perrigo expects more nasal steroid switches, Pfizer consumer sales flat, Sanofi consumer grows nearly 10%

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".